Meridian Small Cap Growth Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Meridian Small Cap Growth Fund Institutional Class MSGRX
- NAV / 1-Day Return 13.88 / −0.07 %
- Total Assets 329.6M
-
Adj. Expense Ratio
1.110%
- Expense Ratio 1.100%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 37%
USD | NAV as of Aug 18, 2026 | 1-Day Return as of Aug 18, 2026, 12:44 AM GMT+0
Morningstar’s Analysis MSGRX
Will MSGRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Axogen Inc | 3.18 | 9M | Healthcare |
Federal Signal Corp | 2.33 | 6M | Industrials |
Hinge Health Inc Ordinary Shares - Class A | 2.26 | 6M | Healthcare |
Goldman Sachs FS Government Instl | 2.17 | 6M | Cash and Equivalents |
Veracyte Inc | 2.11 | 6M | Healthcare |
Consensus Cloud Solutions Inc Ordinary Shares | 2.07 | 6M | Technology |
Apartment List Inc. Series D Preferred Stock | 2.02 | 6M | Corporate |
Definium Therapeutics Inc Ordinary Shares | 1.99 | 5M | Healthcare |
SPX Technologies Inc | 1.98 | 5M | Industrials |
Turning Point Brands Inc | 1.97 | 5M | Consumer Defensive |